|
|||
|
Dr. med. Verena Caelius
|
Research Interests:
Special clinical interests:
Selected References:
Voelcker V.; Sticherling M. Acneiform Skin Lesions as a Side Effect of Therapy with EGFR (epidermal growth factor receptor) Inhibitors in Colon Cancer. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 2011,9,Suppl.1,220-220
Voelcker V, Sticherling M, Bauerschmitz J. Severe ulcerated 'bodybuilding acne' caused by anabolic steroid use and exacerbated by isotretinoin. Int Wound J. 2010 Jun;7(3):199-201
Milkova L, Voelcker V, Forstreuter I, Sack U, Anderegg U, Simon JC, Maier-Simon C. The NF-kappaB signalling pathway is involved in the LPS/IL-2-induced upregulation of FoxP3 expression in human CD4CD25 regulatory T cells. Exp Dermatol. 2009 Oct 21. [Epub ahead of print]
Anderegg U, Eichenberg T, Parthaune T, Haiduk C, Saalbach A, Milkova L, Ludwig A, Grosche J, Averbeck M, Gebhardt C, Voelcker V, Sleeman JP, Simon JC. ADAM10 Is the Constitutive Functional Sheddase of CD44 in Human Melanoma Cells. J Invest Dermatol. 2008 Oct 30. [Epub ahead of print]
Voelcker, V., Gebhardt, C., Averbeck, M., Saalbach, A., Wolf, V., Weih, F., Sleeman, J., Anderegg, U., and Simon, J. (2008). Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Experimental Dermatology 17, 100-107.
Köllisch G*, Kalali BN, Voelcker V, Wallich R, Behrendt H, Ring J, Bauer S, Jakob T, Mempel M, Ollert M. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology. 2005 Apr;114(4):531-41.
*Division of Environmental Dermatology and Allergy GSF/TUM, GSF National Research Center for Environment and Health, Neuherberg, Germany. koellisch@gsf.de
Mempel M*1, Voelcker V1, Köllisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol. 2003 Dec;121(6):1389-96
1 both authors contributed equally to the presented work
*Department of Dermatology and Allergy, Biederstein , Munich, Germany. m.mempel@lrz.tum.de
